PATENT CLAIM ANALYSIS

Application Number: 15771816
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "171000"]

Abstract:
The invention provides synergistic combinations of cannabidiol (CBD) and a second therapeutic agent, such as one or more ChEH/AEBS inhibitors, a naphthoquinone or a derivative thereof, or any combination thereof, effective for the treatment cancer. Compositions containing same and methods of use of same are described.

Claim (Index 3):
The composition of  claim 2 , wherein said selective inhibitor of ChEH/AEBS is 1-[2-[4-(phenylmethyl)phenoxy]ethyl]-Pyrrolidine (PBPE) or tesmilifene (DPPE).

Metadata:
- Claim Count in Document: 129.0
- Percentile: 91.0
- Lexical Diversity: 1.31707
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13690920', '15549496', '11920909', '13953013', '14792046']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7313611569315988
- 35 USC 102 Novelty (BERT): 0.5204657008826272
- Combined Prediction Score: 0.7102716113267017
- Mean Citation Score: 230.085884
- Max Citation Score: 235.90778
- Similarity Product: 136.69744071332693

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test